Velocity Pharma Management, LLC

Track record of Velocity Pharma Management, LLC

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Velocity Pharma Management, LLC

Co-insiders of Velocity Pharma Management, LLC

• 14159 capital (GP), LLCSynvista Therapeutics, Inc.
• Arbet-Engels ChristopheSynvista Therapeutics, Inc.
• Baker Biotech Capital (GP), LLCSynvista Therapeutics, Inc.
• Baker Biotech Capital III (GP), LLCSynvista Therapeutics, Inc.
• Baker Bros. Capital (GP), LLCSynvista Therapeutics, Inc.
• BAKER FELIXSynvista Therapeutics, Inc.
• BAKER JULIANSynvista Therapeutics, Inc.
• Baker / Tisch Capital (GP), LLCSynvista Therapeutics, Inc.
• Berkowitz NoahSynvista Therapeutics, Inc.
• BRANSOME EDWIN D JRSynvista Therapeutics, Inc.
• BRESLOW MARILYN GSynvista Therapeutics, Inc.
• Brown William MichaelSynvista Therapeutics, Inc.
• Collier David JSynvista Therapeutics, Inc.
• CZEREPAK ELIZABETHSynvista Therapeutics, Inc.
• DALBY ALAN JSynvista Therapeutics, Inc.
• DEGROOF ROBERT CSynvista Therapeutics, Inc.
• Drutz DavidSynvista Therapeutics, Inc.
• Durso Jerome BenedictSynvista Therapeutics, Inc.
• Eisenstadt Richard ISynvista Therapeutics, Inc.
• Enright WilliamSynvista Therapeutics, Inc.
• Garg Vipin KSynvista Therapeutics, Inc.
• GENENTECH INCSynvista Therapeutics, Inc.
• GILL JOHNSynvista Therapeutics, Inc.
• Harris Matthew ScottSynvista Therapeutics, Inc.
• HEDSTROM JUDITH SSynvista Therapeutics, Inc.
• Hodges PhilipSynvista Therapeutics, Inc.
• Jordt Raymond MSynvista Therapeutics, Inc.
• Jorkasky DianeSynvista Therapeutics, Inc.
• Koh Bong YSynvista Therapeutics, Inc.
• Lawver Teri LSynvista Therapeutics, Inc.
• MacNab MalcolmSynvista Therapeutics, Inc.
• MCCURDY DAVID KSynvista Therapeutics, Inc.
• MOCH KENNETH ISynvista Therapeutics, Inc.
• MOORE THOMAS ASynvista Therapeutics, Inc.
• NAIMARK GEORGE M PHDSynvista Therapeutics, Inc.
• NOVARTIS AGSynvista Therapeutics, Inc.
• Novartis Bioventures LtdSynvista Therapeutics, Inc.
• NOVITCH MARK M DSynvista Therapeutics, Inc.